<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00997971</url>
  </required_header>
  <id_info>
    <org_study_id>ROS-CL3-001</org_study_id>
    <nct_id>NCT00997971</nct_id>
  </id_info>
  <brief_title>Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein</brief_title>
  <acronym>Rose</acronym>
  <official_title>Phase 3 Safety Study of a Partially Hydrolyzed Rice Protein Formula in Healthy Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sodilac</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sodilac</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess growth and global tolerance in healthy new born
      infants with minor gastrointestinal troubles and/or allergic risk, fed an experimental
      partially hydrolyzed rice protein infant formula.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This objective will result in the study of non-inferiority of the experimental formula in
      terms of variation of weight compared with growth curves after 3 to 6 months of exclusive
      regime with the experimental formula.

      Parents provide informed written consent.

      4 visits are forecasted in pediatric surgeries: V1(inclusion), V2 (2 months), V3 (4 months)
      and V4 (6 months). The last visit corresponds to the beginning of the food diversification
      decided by the pediatrician. Ideally it takes place at 6 months. If the food diversification
      starts at 4 months, then V3 and V4 constitute the same last visit.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Growth parameters</measure>
    <time_frame>2nd, 4th and 6th months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Tolerance</measure>
    <time_frame>3 days before the 2nd and 6th months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atopic diseases (eczema atopic, asthma)</measure>
    <time_frame>2nd and 6th months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Growth</condition>
  <condition>Allergy</condition>
  <arm_group>
    <arm_group_label>Modilac Rose 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infant formula with partially hydrolysed rice protein</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modilac Rose 1</intervention_name>
    <description>Infant formula used for non-breastfed children</description>
    <arm_group_label>Modilac Rose 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term health infants with gestational age ranging from 37 to 42 weeks

          -  Infants less than 1 month old

          -  Non breastfed children at the inclusion

          -  Growth parameter normal

          -  Apgar score &gt; 5 to 7 minutes

          -  Change in the formula because of digestive troubles (colics, gas, regurgitation) or
             risks of allergy

          -  Absence of metabolic, nervous or digestive troubles

          -  Absence of digestive haemorrhage, apnea or dizzy turn

        Exclusion Criteria:

          -  Partial breastfed children

          -  Infants presenting a cow's milk protein allergy

          -  Infants currently participating in another trial

          -  Infants presenting an organic disease involving medicinal or surgical treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Philippe Girardet, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital d'enfants Armand Trousseau</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Aix les bains</city>
        <zip>73100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Asnieres</city>
        <zip>92600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boulogne Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ecully</city>
        <zip>69130</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lyon</city>
        <zip>69005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meaux</city>
        <zip>77100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St Priest en Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2009</study_first_submitted>
  <study_first_submitted_qc>October 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2009</study_first_posted>
  <last_update_submitted>October 19, 2009</last_update_submitted>
  <last_update_submitted_qc>October 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2009</last_update_posted>
  <responsible_party>
    <name_title>Pr Jean-Philippe Girardet (Principal investigator)</name_title>
    <organization>Hôpital d'enfants Armand Trousseau</organization>
  </responsible_party>
  <keyword>Hydrolysed rice protein formula</keyword>
  <keyword>Cow's milk protein allergy</keyword>
  <keyword>Infant formula</keyword>
  <keyword>Gastrointestinal tolerance</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

